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Several mycobacterial antigens, identified by monoclonal ntibodies and patient sera, have been 
found to be homologous to stress or heat-shock proteins (hsp) defined in Escherichia coli and 
yeast. A major antigen recognized by most Mycobacterium leprae-reactive human T cell lines and 
cell wail-reactive T cell clones is a 10-kD protein that has now been cloned and sequenced. The 
predicted amino acid sequence of this protein is 44% homologous to the hsp 10 (GroES) of 
E. coll. The purified native and recombinant 10-kD protein was found to be a stronger stimulator 
of peripheral blood T cell proliferation than other native and recombinant M. l~rae proteins 
tested. The degree of reactivity parallded the response to intact M. leprae throughout the spectrum 
of leprosy. Limiting-dilution analysis of peripheral blood lymphocytes from a patient contact 
and a tuberculoid patient indicated that approximately one third ofM./e~e-reactive T cell precursors 
responded to the 10-kD antigen. T ceU lines derived from lepromin skin tests were strongly 
responsive tothe 10-kD protein. T cell clones reactive to both the purified native and recombinant 
10-kD antigens recognized M. l~rae-specific epitopes as well as epitopes crossreactive with the 
cognate antigen of M. tuberculosis. Further, the purified hsp 10 elicited strong ddayed-type 
hypersensitivity reactions in guinea pigs sensitized to M. leprae. The strong T ceil responses against 
the M. leprae 10-kD protein suggest a role for this heat-shock cognate protein in the 
protective/resistant responses to infection. 
U nderstanding resistance toleprosy and other infectious diseases caused by intracellular pathogens requires 
identification ofantigens that stimulate cell-mediated immune 
responses. The fact that Mycobacteriura leprae remains one of 
the few bacterial pathogens ofhumans that has not been suc- 
cessfully cultivated in vitro poses a serious challenge to the 
identification and purification of protective antigens. Several 
biochemical, immunological, nd molecular approaches have 
recently been used for identification and characterization f 
protein antigens of the leprosy bacillus (1-6). Over 10 an- 
tigens have been identified and cloned by use of monoclonal 
antibodies or patient sera. Of these, the 70-, 65-, 36-, 35-, 
18-, and 17-kD antigens elicit T call reactivity in a small 
number of sensitized individuals, although it remains unclear 
which, if any of them, has a significant role in protective 
immunity (7-12). Four of these mycobacterial antigens hare 
significant homology with highly conserved heat-shock pro- 
teins (hsp) 1 or stress proteins in Escherichia toll, yeast, and 
other organisms (6). 
A number of new strategies have been developed for use 
of T cells to screen and identify mycobacterial antigens that 
may be involved in protective immune responses. T cell clones 
have been used directly to screen pools of phage clones from 
the recombinant ~,gt 11 library ofM. leprae (13). Several groups 
1 Abbreviations used in this paper: hsp, heat-shock protein; DTH, delayed- 
type hypersensitivity; IPTG, isopropylthiogalactoside; FPLC, fast protein 
liquid chromatography; MBP, maltose-binding protein. 
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have used the T cell Western blot approach, where PBMC, 
T cell lines, or clones are employed to screen proteins of 
M. leprae separated by SDS-PAGE and blotted onto nitrocel- 
lulose membranes for analysis (4, 14-17). Previous studies 
of M. leprae antigens from our laboratories using the T cell 
Western blots indicated that most T cell lines from reactive 
donors recognized an antigen in the molecular mass range 
of 7-10 leD (4). We now report the isolation, sequencing, 
and expression of the gene encoding this 10-kD protein as 
well as our evaluation of the ability of purified native and 
recombinant protein to stimulate T cell responses in reactive 
individuals in vitro and specific delayed-type hypersensitivity 
(DTH) responses in vivo. 
Materiah and Methods 
Patients. Patients with leprosy were diagnosed at the Los An- 
geles County Hansen's Disease Clinic (Los Angeles, CA) and the 
Institute of Biomedicine (Caracas, Venezuela). They were classified 
according to the criteria of Ridiey and Jopling (18). 
Some patients with tuberculoid leprosy were skin tested with 
0.1 ml of lepromin A (armadillo derived, cobalt-irradiated, 2 x 
10 + badlli/ml) given intradermally. Punch biopsy was performed 
at 21 d on reactions with an induration of >t5 mm in diameter. 
Antigens. Armadillo-derived M. leprae was obtained from 
R.. J. W. Rees through the IMMLEP Program, WHO (Geneva, 
Switzerland). The biochemical purification of the native proteins 
of 21//./eprae used in this study has been extensively described (5). 
These were the 10-kD (previously known as a 14-kD protein), the 
3-, 17-, 22', 28-, and 35-kD proteins. The 10-kD protein of Mycobac- 
teriura tuberculos/s (Erdman) was purified as described for the M./eprae 
product. Purified recombinant 65-kD and 70-kD proteins were 
kindly provided by Dr. Van Embden (National Institute of Public 
Health, Bilthoven, Netherlands), and the 18-kD protein was sup- 
plied by Dr. J. Watson (University of Auckland, New Zealand). 
The 27-met representing the NH2-terminal sequence of the M. 
/eprae 10-kD protein was synthesized ona peptide synthesizer (430A; 
Applied Biosystems, Inc., Foster City, CA) and purified by reverse 
phase FIPLC. Overlapping peptides of M. tuberculosis 10-kD an- 
tigen were a generous gift from Dr. Percy Minden (Scripps Clinic 
and Research Foundation, La Jolla, CA). Tetanus toxoid was ob- 
tained from the Massachusetts Department ofHealth (Boston, MA). 
The concentration of antigens and peptides used was determined 
by several titration experiments on responsive cells. 
T Cell Western Blot. Immunoreactive M. leprae antigens were 
identified by the T cell Western blot method (4). Briefly, M. leprae 
sonicate (4 mg/ml) was subjected to electrophoresis on 5-20% gra- 
dient SDS-PAGE gel to separate he proteins. After electrophoresis 
proteins were transferred onto nitrocellulose membrane, cut into 
2 x 50-mm strips, dissolved in DMSO, and reprecipitated bythe 
addition of 0.05 M bicarbonate buffer (pH 9.6) to convert nitrocel- 
lulose into fine antigen-bearing particles. Theprecipitate was washed 
with PBS and resuspended in 0.6 ml of RPML For lymphoprolifer- 
ative assays, 10/~1 of the suspension was added to cultures. 
Isolation and NHrterminal Sequence oft0 kD Protein. The 7-10- 
kD major T cell--stimulating protein was isolated by the following 
procedure. A T cell Western blot was performed on M. leprae pro- 
teins separated by SDS-PAGE using part of the gel (three lanes), 
while the remaining el was saved for elution of relevant proteins. 
The proteins were electroeluted (Extraphor Electrophoretic Con- 
centrator; LKB Instruments, Inc., Bromma, Sweden) from the area 
of polyacrylamide g ls corresponding tothe Western blot nitrocel- 
lulose strips that induced proliferation of the T cell clones/lines 
previously reactive to a protein in this molecular mass range. By 
use of this procedure, 7-10-kD molecular mass range proteins were 
pooled from four gels and concentrated with a microconcentrator 
centricon-3 (Amicon, Beverly, MA). The polypeptides were resolved 
further by two-dimensional PAGE; two-dimensional gels were per- 
formed by Protein Databases, Inc. (Brookhaven, NY) using pub- 
lished methods (19). After electrophoresis the proteins were visual- 
ized with silver stain. 
Proteins from an identical preparative two-dimensional gel were 
transferred onto an Immobilon (Millipore, Bedford, MA) mem- 
brane, visualized with coomassie blue, and both the protein spots 
were directly subjected to microsequencing at the University of 
Wisconsin Biotechnology Center (Madison, WI). The sequence 
of 24 NHz-terminal mino acids of each spot was determined from 
15 pmol of protein. 
Screening of )~gt 11 M. leprae Library. The gene encoding the 
10-kD protein ofM. leprae was cloned by use of synthetic oligonu- 
deotide probes to screen the ~,gt 11 library of M. letnae genomic 
DNA. Initially these probes were designed to correspond with the 
amino add sequence ofthe NH2 terminus, based on the most fre- 
quently used codons reported in the nucleotide sequences of the 
genes encoding mycobacterial proteins. Subsequent screening was 
performed using probes designed to be homologous to the 
5'-nucleotide s quence ofthe badlle Calmette-Guerin (BCG) pro- 
tein of M. tuberculosis. 
The recombinant )~gt 11 library of M. leprae genomic DNA 
(provided by R. A. Young, through the IMMLEP Program of 
WHO) was screened by colony hybridization using two 32p_ 
labeled overlapping 23-mer oligonucleotide probes. The recombinant 
)~gt 11 phages (50,000 PFU/150-mm dish) were plated on E. coli 
strain Y1090 as described (1). Standard procedures for preparing 
nitrocellulose filter plaque replicas and carrying out hybridization 
reactions were used (20, 21). Recombinant plaques howing posi- 
tive hybridization were isolated and purified to homogeneity. DNA 
inserts of all eight positive dones were analyzed by restriction map- 
ping using the common restriction enzymes. All clones had similar 
restriction patterns. These recombinant clones were also examined 
for the expression f10-kD protein by use of the crossreactive rabbit 
anti-BCG-a antibodies (gift from Dr. Percy Minden). One of the 
three positive clones containing 2.2-kb M. leprae DNA fragment 
was subjected to nucleotide sequencing. 
DNA Sequencing. The 2.2-kb M. leprae DNA insert was iso- 
lated and digested with XhoI and BamHI to obtain three XhoI- 
BamHI fragments. These fragments were subcloned inpBluescript 
II KS+ phagemids (Stratagene, La Jolla, CA), and grown in DHS~ 
host cells. The nucleotide sequence of the subcloned DNA frag- 
ments was determined by the dideoxy chain termination method, 
using a sequenase kit version 2.0 (U.S. Biochemical Corp., Cleve- 
land, OH) according to the instructions provided. Both strands 
of the DNA were sequenced. 
Expression of lO-kD Protein in E. coil So that only the coding 
region of the gene encoding the M. leprae 10-kD protein would 
be expressed, a EcoRI site was engineered immediately 5'of the 
start codon of the gene and a XbaI site was incorporated right 
after the stop codon at the 3' end by PCR using a DNA thermal 
cycler and the Taq Polymerase Kit (Perkin Elmer Cetus Instruments, 
Norwalk, CT) according to directions of the manufacturers. The 
PCR fragment consisting of 320 nucleotides was digested with 
EcoRI, XbaI and subcloned into the same sites of the pMAbc ex- 
pression vector (generous gift from New England Biolabs, Beverly, 
MA). Vector containing the fused gene was transformed into the 
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E. coli strain PK 722 for expression by the standard procedures for 
DNA manipulation. In this construct the gene is cloned down- 
stream from real E gene encoding maltose binding protein (MBP). 
A notable feature of this vector is the presence of a sequence oding 
for a four-amino acid recognition site of the protease factor Xa 
just before the start site of the inserted gene at the 5' end. Protein 
is expressed from the strong P,~ promoter as an MBP fusion 
product. 
Preparation and Purification of Recombinant lO-kD Protein. 
Recombinant antigen was prepared inaccordance with instructions 
provided by New Enghnd Biolabs. Briefly, cells containing the fu- 
sion plasmid were grown to log phase, and production of fusion 
protein was induced with 0.3 mM isopropylthiogalactoside (IV/G) 
at 37~ for 2 h. The pelleted bacteria were sonicated in the lysis 
buffer containing 0.25% Tween-20. After centrifugation at 9,000g, 
the fusion protein was purified from the crude extract by affinity 
chromatography on amylose resin column. The MBP fusion pro- 
tein binds to amylose. After extensive washes of the column, the 
fusion protein was duted with 10 mM maltose. Subsequently, the 
recombinant 10-kD protein was cleaved from MBP with 1% factor 
Xa at room temperature for 24 h. After cleavage the 10-kD protein 
was separated from MBP using fast protein liquid chromatography 
(FPLC) (Pharmacia Fine Chemicals, Piscataway, NJ), over an anion 
exchange column (Mono Q) at pH 7.4 with a 0-0.3 M NaC1 linear 
gradient. 
Aliquots of the fractions were analyzed on 15% SDS-PAGE. Frac- 
tions containing purified 10-kD protein were pooled and dialyzed 
extensively against physiologic saline before use. 
Western Blot Analysis. Electrophoresed proteins were transferred 
electrophoretically onto a nitrocellulose membrane. The membrane 
was washed with Tris-buffered saline, incubated for I h in 2% BSA 
for blocking, and incubated overnight with antibody (1:103 dilu- 
tion) as described (22). The mAbs specific for the 10-kD protein 
of M. tuberculosis (SA-12, provided by Dr. Percy Minden) and specific 
for the protein from M. leprae (CS-01, supplied by B. Rivoire, 
Colorado State University, Fort Collins, CO) were also used. After 
washing, the filters were incubated with peroxidase-conjugated n- 
tiserum. Finally, the color reaction was developed with 4-chloro-1- 
naphthol in the presence of H2Oz. 
Assay of PBMC. PBMC (2 x 103) were cultured in 200-#1 
flat-bottomed wells in RPMI (Gibco Laboratories, Grand Island, 
NY) containing 10% AB serum, and antigen or media control. 
[3H]Thymidine (1 #Ci) was added to the cultures after 5 d, and 
the cells were harvested 21 h later. Assays were performed in 
triplicate. 
11_,2 Expanded T Cell Lines and Clones. Lymphocytes were ex- 
tracted from skin biopsy specimens of leprosy lesions as described 
(23, 24). T cell lines of cells activated in situ by M. leprae antigens 
were established by culturing in the presence of II_,2 alone. These 
T cell lines were used to detect he antigens that stimulate T cells 
in vivo. In addition, T call clones from M. leprae 10-kD expanded 
T cell lines from peripheral blood were obtained by the method 
of limiting dilution (4). 
T cell lines or clones, free of Ib2, were cultured in the presence 
of autologous irradiated feeders as APC. An assay was set up in 
triplicate at a density of 104 cloned cells per 10 s feeders in the pres- 
ence of various mycobacterial antigens. Control cultures received 
either no antigen, 10% IL-2 alone, or an irrelevant antigen such 
as tetanus toxoid. After 3 d, cultures were pulsed with [3H]thymi- 
dine and harvested 4 h later. 
Limiting Dilution Analysis. The precursor f equency ofT lym- 
phocytes reactive to M. leprae versus the native 10-kD antigen 
was determined by limiting-dilution analysis as previously described 
(2s, 26). 
Results 
Identification of Gene Encoding the lO-kD Antigen. The im- 
munoreactive protein determinants of M. leprae diciting T 
cell responses were previously identified by screening pro- 
teins from M. leprae sonicate separated on SDS-PAGE with 
T cell lines/clones developed from lepromin-positive individuals 
stimulated in vitro with M. leprae or purified cell wall prepa- 
rations (4). One of the two major T cell-stimulating pro- 
teins found was in the 7-10-kD molecular mass range. To 
characterize the proteins further, they were dectroduted from 
the strips of polyacrylamide gels corresponding to those in- 
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Figure 1. SDS-PAGE analysis of 
7-10-kD M./eprae proteins. (/1) To iden- 
tify the region f the gel containing the 
electrophoresed M. leprae proteins from 
which the 7-10-kD T cell-stimulating 
antigen should be ehted, the technique 
of T cell Western blot was employed. 
This representative experiment shows
the proliferative responses ofa T cell 
line (previously reactive to a protein in 
the 7-10 kD molecular mass range) to 
proteins transferred from a portion of 
a gel. Proteins were ev ntually electroe- 
hted from the region f the gel corre- 
sponding to the nitrocelhlose strips 
inducing lymphoproliferation. (B) 
M. leprae sonicate (4 mg/ml) was sub- 
jected to dectrophoresis ona 5-20% 
gradient SDS-PAGE. The gel was 
stained with coomassie blue. (C) T cell 
stimulating proteins eluted from 7-10 
kD size range were resolved further by 
two-dimensional PAGE and stained 
with silver. 
M. tuberculos is  10kD 
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E. coli GroES 
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E. coli GroES 
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Figure 2. Comparison of the de- 
duced amino acid sequences of 10-kD 
hsp in M. leprae, M. tuberculosis and 
E. coli (GroES). The EMBL accession 
number for the DNA sequence of the 
gene encoding the M./epme 10-kD pro- 
tein is X594D. 
ducing proliferation of the T cell clones reactive to 7-10-kD 
protein (Fig. 1, A and B). The eluted material resolved into 
two spots on two-dimensional PAGE (Fig. 1 C). Proteins 
from an identical two-dimensional gel were transferred to 
an Immobilon membrane, visualized with coomassie blue 
stain, and subjected to protein microsequencing. The NH2- 
terminal sequence of the 24 amino acids was identical to both 
protein spots. This amino acid sequence had striking homology 
to the NHz terminus of the M. boris BCG-a protein, a 10- 
kD hsp differing only at residues 4, 15, and 17 of the first 
20 amino acids (27-30). The sequence of the first 30 amino 
acid residues of the major protein of M. leprae, isolated by 
biochemical means and called the major cytosotic protein-I 
or the 14-kD protein, was also identical to this protein (5). 
Further, by use of two overlapping 23-met oligonucleo- 
tide probes based onthe NH2-terminal amino acid sequence, 
the gene encoding the 10-kD protein of M. leprae was iso- 
lated from the Xgt 11 recombinant library ofM. leprae. DNA 
inserts from all eight recombinant clones showing positive 
hybridization were mapped with restriction enzymes, and 
all had similar estriction patterns. The EcoRI insert of 2.2 
kb from one of the recombinant clones was subjected to DNA 
sequence analysis. The sequence revealed a 300-bp coding re- 
gion beginning with GTG and encoding a protein comprised 
of 99 amino acids, starting with alanine and with the predicted 
molecular mass of 10.8 kD. The deduced amino add sequence 
of the 10-kD protein ofM. leprae (Fig. 2) bears 90% identity 
with the 10-12-kD BCG-a antigen of M. tuberculosis, which 
was reported to have homology with hsp GroES of E. coli 
and htpA, a gene product of Coxiella burnetii (28, 29). The 
M. leprae 10-kD protein has 44% identity with GroES of 
E. coli, confirming that the 10-kD hsp are widely conserved 
among different organisms (31). 
Our previous tudies demonstrated that the 7-10-kD pro- 
tein was highly effective in inducing lymphoproliferation of 
T ceils from skin-test-positive individuals. Because only small 
quantities of native protein can be obtained from M. leprae 
(5), we expressed the 10-kD protein in E. coli to further evaluate 
its immunological reactivity. 
Expression of Recorabinant M. leprae hsp10 in E. coil The 
gene encoding the M. leprae 10-kD antigen was expressed 
in E. coli using pMAbc expression vector developed at New 
England Biolabs. This vector allows the foreign protein to 
be expressed in large amounts by fusing it to real E gene en- 
coding MBP from a strong Ptac promoter. Also included is 
a specific recognition site for the protease, factor Xa, which 
allows the protein of interest to be cleaved from MBP after 
purification on an amylose-affinity column. Fig. 3 A shows 
the SDS-PAGE analysis ofboth the extract of cells expressing 
10-kD antigen as fusion protein and purified fusion protein 
before and after cleavage with factor Xa. On average, 30-40 
Figure 3. SDS-PAGE analysis of the recombinant 10-kD protein. (A) 
Coomassie bhe-stained SDS-PAGE orE. coli extract containing the recom- 
binant plasmid (pMAL-10 kD) before and after induction w th IFIG (lanes 
1 and 2); purified fusion protein (lane 3); fusion protein cleaved with pro- 
tease, factor Xa, to rdease MBP, and the 10-kD protein (lane 4); purified 
recombinant 10-kD antigen separated on FPLC after cleavage (lane 5). (B) 
Immunoblots of recombinant MBP-10-kD fusion protein after cleavage 
(lane I); recombinant 10-kD antigen purified by FPLC on Mono Q column 
(lane 2), probed with mAb CS-01 raised against thepurified native 10-kD 
protein of M. /eprae. This mAb does not crossreact with M. tuberculosis 
or E. coli hsp 10 (data not shown). 
de l ta  cpm x 10 -3  
200  i 
150~h ....... 
100  . . . . . . .  
50  
0 
TUBERCULOID LEPROMATOUS 
(n -23)  (n-11) 
nat ive  10 kD I I i .  l eprae  
Figure 4. Comparison of PBMC responses to M. leprae sonicate (10 
#g/ml) and the native 10-kD antigen (5/~g/ml) in patients with tuber- 
culoid and lepromatous leprosy. 
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mg of fusion protein was obtained per liter of culture. After 
denying with factor Xa, the llYkD protein was separated from 
MBP on an anion-exchange (Mono Q) column using FPLC. 
Both the fusion protein and purified recombinant 10-kD an- 
tigen reacted strongly with the mAb CS-01 (Fig. 3 B), as 
did the highly abundant native 10-kD protein of M. leprae 
against which the monodonal was raised (data not shown). 
The M. leprae lO-kD Antigen Is a Potent Stimulator of PBMC 
Responses. We evaluated the lymphocyte responses of pa- 
tients with leprosy throughout the disease spectrum to the 
purified M. leprae hspl0 to ascertain whether the T cell re- 
sponse paralleled the dinical form of the disease. As shown 
in Fig. 4, positive PBMC responses were detected in tuber- 
culoid patients, who have a resistant form of the disease, but 
negligible responses were observed in lepromatous patients, 
who have multibacillary disease. The magnitude of the re- 
sponses eemed to paralld those to whole M. leprae in a large 
number of tuberculoid onors tudied. Lepromatous donors, 
specifically unresponsive toM. leprae were also unable to re- 
spond to the 10-kD antigen; this finding suggests hat T cells 
reactive to the 10-kD antigen were either not present in blood 
or unable to respond in these individuals. Therefore, the na- 
tive 10-kD antigen is a strong stimulator ofT cell responses 
in leprosy patients, and responses correlate with the clinical 
spectrum of disease. 
T Cell Clones Recognize Specific and Crossreactive Epitopes 
ofM. leprae lO-bD Protein. T ceU clones were derived from 
the blood of donors who demonstrated strong in vitro re- 
sponses to the 10-kD protein ofM. leprae (Fig. 5). Two such 
clones were found to react to the synthetic NH2-terminal 
27-met, one M. leprae-specific (Fig. 5 A), the other cross- 
reactive with M. tuberculosis (Fig. 5 B). A third done was 
M. leprae specific but recognized an epitope distal to the 
NHz-terminal 27-met (Fig. 5 C). The data indicate the pres- 
ence of specific and crossreactive epitopes on the NH2- 
terminal end of the 10-kD protein from M. leprae. 
T cell clones that recognized the NH2-terminal peptide 
of the 10-kD antigen were used as probes to determine the 
immunologic oncordance of the native and recombinant 
10-kD protein. The E. coli lysate containing fusion protein 
was separated by SDS-PAGE, transferred to a nitrocdlulose 
membrane, and solubilized in DMSO. The T cell clones reacted 
to the fusion protein present in the E. coli lysate as visualized 
by coomassie blue stain of the gel (Fig. 6 A). Further, the 
purified recombinant 10-kD antigen obtained after deavage 
of fusion protein and purification on FPLC was tested for 
immunoreactivity. Three out of four reactive individuals 
showed equivalent responses to the purified recombinant 10- 
kD and native 10-kD protein of M. leprae (Fig. 6 B). 
Comparison ofT Cell Reactivity to the IO-kD Antigen Rela- 
tive to Other Native and Recombinant Proteins. To assess the 
importance ofthe 10-kD antigen, in relation to other M. leprae 
proteins, in inducing peripheral blood T cell responses of 
lepromin-positive patients and contacts, lymphocyte prolifer- 
ation to available M. leprae antigens was measured in vitro. 
As shown in Fig. 7, when peripheral blood cells from 
lepromin-positive donors, either patients with tuberculoid 
leprosy (n = 7) or healthy contacts of leprosy patients (, 
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Figure 5. Patterns ofT ceil clone reactivity othe M. leprae 10-kD an- 
tigen. The results how three different reactivity patterns based on epi- 
tope recognition. Clones were tested against native 10-kD antigens of
M. leprae (5 #g/m1) and M. tuberculosis (5 #g/ml) and synthetic peptides 
(10/.Lg/ml). (.4) An M. leprae-spedfic NH2-terminal peptide-reactive T 
cell done. (B) An M, leprae-M, tuberculosis crossreactive, NHa-terminal 
peptide-reactive T cell clone. (C) An M. leprae-specific, NH2-terminal 
peptide-nonreactive T c ll done. NT, not tested. 
-- 4), were tested for their responsiveness to fractions en- 
riched for known antigenic components prepared with HPLC, 
highest responses were found with the 10-kD protein, fol- 
lowed by the 3-kD fraction, which is a mixture of several 
peptides (5), and the 17-kD protein. Responses to the previ- 
ously identified stress protein homologs of 70, 65, and 18 
kD, where present, were significantly lower. These results 
strongly indicate that, among the available M. lepme proteins, 
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Figure 6. T cell responses to the native 
and recombinant 10-kD antigen. M. leprae 
sonicate was tested at 10/tg/ml, the native 
10-kD antigen at 5/~g/ml, and the recom- 
binant 10-ED antigen at I/~g/ml. (A) A 
T cell done reactive to the native 10-kD 
antigen and the NH2-terminal peptide 
identifies the recombinant MBP-10-kD fu- 
sion protein on a T cell Western blot. (B) 
PBMC responses in four tuberculoid pa- 
tients to the native and recombinant 10-kD 
antigen. 
the 10-kD protein appears to be most potent in stimulating 
T cells; with in vitro responses that were comparable to those 
elicited by whole mycobacteria. 
Precursor Frequency Analysis of lO-kD-reactive T Cells. For 
comparison of the precursor frequencies of 10-kD- and 
M. leprae sonicate-reactive T cells, limiting-dilution analysis 
was performed on peripheral blood T cells from a skin- 
test-positive patient contact and a patient with tuberculoid 
leprosy. Fig. 8 shows the results from the patient contact. 
In this donor 1/768 T cell precursors were reactive to whole 
M. leprae sonicate, and 1/2,191 were reactive to the native 
10-kD antigen. Similar results were obtained in the study 
of the tuberculoid patient; 1/400 precursors were reactive to 
the M. leprae sonicate as compared with 1/1,150 that were 
reactive to the 10-kD antigen. Therefore, in both subjects, 
about one third of the M. leprae-reactive T cells seem to be 
responding to the 10-kD protein. 
Potential Use of M, leprae lO-kD Antigen as a Skin-test Re- 
agent. When T ceils were derived from tuberculoid lesions 
and cultured in the presence of II.-2 alone to expand those 
ceils activated in vivo to express IL-2 receptors, reactivity was 
found to M. leprae cell walls. The model for cutaneous DTH 
in leprosy is the 3-wk granulomatous response to intradermal 
challenge with M. teprae, called the Mitsuda skin-test reac- 
tion (18). Therefore, we derived T cells from Mitsuda reac- 
tions and expanded these cells in the presence of 1I.,2 for 1-2 
wk without antigen. These T cell lines were found to 
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10 #g/ml, except he 10-kD antigen, which was tested at 5 #g/m1. The 
70; 65; and 18-kD antigens are recombinant proteins, the 35-, 28-, 22-, 
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Figure 9. Reactivity of a T cell line derived from a lepromin skin test 
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those cells stimulated by antigen in vivo. The resuhs are shown for one 
representative patient; four patients were studied. 
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proliferate equally well in response to the 10-kD antigen as 
to whole M./eprae, but not to the unrelated antigen. This 
observation i dicates that the responsive T cell component 
fundamental to the cutaneous measure of DTH in leprosy 
is the 10-kD reactive T cell (Hg. 9). 
Although the 10-kD antigen of M. leprae demonstrated 
induction of T cell reactivity in vitro, in vivo studies were 
required to assess the importance ofthis antigen for inducing 
cell-mediated immunity. Thus, to examine the DTH reac- 
tive in vivo, guinea pigs sensitized to M./eprae were tested 
1-2 mo later with intact M./eprae and with recombinant 10-kD 
antigen. Fig. 10 shows that the 10-kD antigen was as effec- 
tive as M./eprae in elidting DTH responses in these immunized 
animals. 
DlscHs~on 
The mechanism by which the host responds to and 
eliminates infection is a central issue in our understanding 
of the immune response to pathogens. For many intracel- 
lular organisms, uch as M./eprae, the T cell response iscru- 
cial. Our data provide evidence that the 10-kD antigen of 
M. leprae is a strong stimulator of T cell responses: (a) The 
M. leprae 10-kD protein elicited PBMC responses similar in 
magnitude to the response to M. leprae bacillus, and these 
responses paralleled the clinical and immunologic spectrum 
of disease. (b) The 10-kD protein evoked greater PBMC re- 
sponses than other purified and recombinant antigens. (c) 
Limiting-dilution analysis performed in two M. leprae-reac- 
tire individuals indicated that approximately one third of 
M./eprae-reacfive T cell precursors responded to the M./eFrae 
10-kD antigen. (d) T cells derived from a lepromin skin test 
(Mitsuda reaction) showed marked proliferation i response 
to the M./eprae 10-kD antigen. (e) Like intact M. let, rae, the 
M./eprae 10-kD antigen elicted DTH responses in sensitized 
guinea pigs. (j) T cell clones recognized specific and cross- 
reactive pitopes on the M./eprae 10-kD antigen. (g) T cells 
responded similarly to the native and recombinant forms of 
this antigen. 
An important finding of the present study was that the 
M. leprae 10-kD protein, a major T cell antigen, shares 
significant homology with GroES of E. coli (31). In E. coli, 
the GroES gene is contained ina single GroE operon encoding 
another stress protein, GroEL, with which it forms a hetero- 
dimer containing six to eight GroES subunits and 14 GroEL 
suhunits forming a complex composed of two stacked tings 
each containing seven subunits of GroEL (31). The GroEL 
and GroES are reported to he among the most abundant pro- 
teins in the cell. The hspl0 is an essential gene in E. coli and 
yeast, and it functions as a chaperonin enabling transport and 
Figure 10. DTH reactions dieted by recombinant 10-kD antigen. Guinea pigs immunized with 500 ~g of killed M./eprae in saline were skin tested 
I mo hter with (1) 10 ~g/0.1 nd M./epme; (2) 0.7 ~tg, (3) 2.2 ~tg, (4) 6.6 ~tg, and (5) 20.0 ~g/0.1 nd of reeomblnant 10-kD antigen, injected intrader- 
maUy. The orientation of the skin reactions i as follows: F~ 
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folding of molecules across membranes (31, 32). While its 
function in mycobacteria is unknown, its expression i both 
cytosol and purified cell walls is consistent with its functioning 
as a chaperonin. 
Since stress proteins are highly conserved across many 
genera, the ability of an immune host to recognize these pro- 
teins as antigens raises fundamental questions about he regu- 
lation of the immune response (33). On the one hand, the 
ability of the immune system to recognize stress proteins pro- 
vides the ability to react with the wide variety of pathogens 
that express these antigens. Therefore, if hsp are involved in 
providing protective immunity to one pathogen, the highly 
conserved nature of heat-shock cognates could result in some 
level of crossresistance to another. Such a hypothesis has been 
invoked to explain the function ofy/~ T cells, which in cer- 
tain experimental systems appear to recognize the mycobac- 
terial 65-kD hsp (34). Furthermore, the ability of the host 
to recognize cognate autologous stress proteins would facili- 
tate recognition and disposal of an infected, hence stressed, 
host cell (35). Of course, if the immune response isdirected 
against species-specific epitopes, this kind of crossreactive im- 
munity would not be seen. On the other hand, the cross- 
reactive nature of stress proteins may, in some MHC types, 
inappropriately result in the autoimmune r sponses, for ex- 
ample, as implicated by the response of patients with rheu- 
matoid arthritis to the 65-kD antigen (36). The regulatory 
mechanisms bywhich the immune system can direct a strong 
response to a bacterial stress protein, yet not destroy self, are 
not well understood. The identification ofthe M./eprae GroES 
homologue as a major T cell stimulating antigen provides 
an opportunity to study the regulation of the immune re- 
sponse to such stress proteins. 
The identification ofthe M. leprae 10-kD protein as a major 
stimulator of the T cell response in immune and resistant 
individuals has certain implications for control of leprosy. 
Leprosy affects several million people worldwide and is a 
tremendous health and economic burden on developing coun- 
tries. A key issue is the identification of infected individuals 
who may be incubating the disease and may be at risk for 
spreading the disease to susceptible individuals. The dbcel- 
opment of a sensitive skin-test reagent with specificity for 
M. leprae infection, analogous to the purified protein deriva- 
tive (PPD) used to assess infection by M. tuberculosis, would 
help in early detection of infection. Lepromin, prepared from 
infected multibacillary human or infected armadillo tissues, 
is the current standard (37). However, the lack of uniformity 
and the high cost of lepromin significantly hamper epidemi- 
ologic research as well as leprosy control (38). Since our 
findings uggested that a major T cell component oflepromin 
reactivity in vitro was directed against he 10-kD antigen, 
the purified recombinant protein was tested in vivo in M. 
leprae-sensitized guinea pigs and was found to be a very strong 
skin-test antigen. Clinical studies are underway to ascertain 
whether it can discriminate between lepromin-positive and 
lepromin-negative patients with leprosy. 
The use of multiple drug therapy has recently affected the 
transmission fleprosy (39). Yet the side effects of these drugs 
as well as the difficulty and cost of administering them have 
stimulated research toward development of vaccines against 
leprosy. It is now feasible to generate subunit or live recom- 
binant vaccines by use of several adjuvant or vector systems. 
Since BCG was found to have some degree of protective fficacy 
against leprosy in early trial studies, one such vaccine vehicle 
is obviously recombinant BCG, and it would be possible to 
express any M. leprae antigen thought o be required for pro- 
tection in rBCG (4042). The fundamental challenge r mains 
the identification ofM, leprae antigens required for protection. 
In summary, the present data indicate that the 10-kD an- 
tigen of M. leprae is a major T cell antigen, and it may have 
use in the immunoprophylaxis of leprosy. Further studies are 
needed to determine its role in inducing protective immu- 
nity and determining the mechanism whereby ahost reacts 
to stress antigens of pathogens, but yet is prevented from 
reacting to the homologous proteins in the "self" The present 
results provide a framework for addressing such issues. 
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